Ramelteon , a selective melatonin receptor agonist, is the first member of a novel class of hypnotics. It is approved for the treatment of insomnia characterized by sleep onset difficulties in the US and Japan, but not in Europe.

Pharmacokinetic and pharmacodynamic evaluation of ramelteon : an insomnia therapy / Spadoni, Gilberto; Bedini, Annalida; Lucarini, Simone; Mor, Marco; Rivara, Silvia. - In: EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY. - ISSN 1742-5255. - 11:7(2015), pp. 1145-1156. [10.1517/17425255.2015.1045487]

Pharmacokinetic and pharmacodynamic evaluation of ramelteon : an insomnia therapy

MOR, Marco;RIVARA, Silvia
2015

Abstract

Ramelteon , a selective melatonin receptor agonist, is the first member of a novel class of hypnotics. It is approved for the treatment of insomnia characterized by sleep onset difficulties in the US and Japan, but not in Europe.
Pharmacokinetic and pharmacodynamic evaluation of ramelteon : an insomnia therapy / Spadoni, Gilberto; Bedini, Annalida; Lucarini, Simone; Mor, Marco; Rivara, Silvia. - In: EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY. - ISSN 1742-5255. - 11:7(2015), pp. 1145-1156. [10.1517/17425255.2015.1045487]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11381/2795295
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 5
  • ???jsp.display-item.citation.isi??? 4
social impact